Quantcast

Latest Fecal incontinence Stories

2011-04-25 05:55:00

MINNETONKA, Minn., April 25, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products are scheduled to be presented at three upcoming professional meetings. The meetings include...

2011-01-31 08:00:00

GREENWICH, Conn., Jan. 31, 2011 /PRNewswire/ -- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca® System for Bowel Incontinence or Bowel Control Disorder (BCD). "Today's FDA clearance of the MDRF1 is the culmination of significant investment and design efforts by...

2010-09-23 08:27:00

MINNEAPOLIS, Sept. 23 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF...

2010-05-03 14:21:06

More research exploring the health risks and benefits of diet and medication yielded surprising findings.  These studies are being presented at Digestive Disease Week® (DDW®) 2010. DDW is the largest international gathering of physicians and researchers in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Links Between Heartburn Medication and Cardiac Birth Defects The use of common anti-reflux medications during...

2010-04-18 07:00:00

ORLANDO, Fla., April 18 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal® FMS for traditional fecal management methods. The cost savings are mainly due to a reduction in time required for nursing staff to manage fecal incontinence.(1) This study was presented at the...

2010-04-08 05:30:00

MINNEAPOLIS, April 8 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products to treat voiding dysfunctions, today announced that Monday, April 12, the company's Urgent® PC Neuromodulation System is expected to be featured in a segment of the popular television program "The Doctors." The Urgent PC System is a proprietary, minimally invasive, percutaneous tibial nerve...

2010-03-23 05:00:00

MINNEAPOLIS, March 23 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is a nonsurgical system for treatment of urinary urgency, urinary...

2010-03-01 05:30:00

MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of the SUmiT Trial of its Urgent® PC Neuromodulation System that will be published in the April 2010 print edition of THE JOURNAL OF UROLOGY® and is now available on line. The Urgent PC system is a proprietary, minimally...

2010-02-22 08:00:00

SKILLMAN, N.J., Feb. 22 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today the launch of Flexi-Seal®(TM) SIGNAL(TM) Fecal Management System (FMS). Now available in the U.S., U.K. and other Key European markets, Flexi-Seal®(TM) SIGNAL(TM) FMS has been enhanced with key new features, including a unique signal indicator that pops to assist clinicians in...

2009-12-07 07:23:00

UPPSALA, Sweden and EDISON, N.J., Dec. 7 /PRNewswire/ -- Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA(TM) pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence. Q-Med AB and Oceana Therapeutics, Inc. intend to submit a PMA application to the FDA during the first quarter of 2010 based on the results of this study. "This study is the ultimate result of years of hard work as we developed a product using our minimally...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related